SCHEMBL21630173

SCHEMBL21630173

CC(Oc1cc(F)c2c(-c3ccccc3)cc(=O)oc2c1)C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.68
▸ HPGD P15428 4/20 0.68
▸ KDM4E B2RXH2 2/20 0.56
▸ RECQL P46063 1/20 0.56
▸ POLB P06746 1/20 0.53
▸ APEX1 P27695 1/20 0.52
▸ KMT2A Q03164 2/20 0.50
▸ ALOX15 P16050 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ MAP1LC3B Q9GZQ8 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.46
▸ MEN1 O00255 1/20 0.45
▸ KLK7 P49862 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21629598 0.89 ALDH1A1 (0.54) ALDH1A1HPGDKDM4ERECQLPOLB
SCHEMBL21629591 0.88 ALDH1A1 (0.55) ALDH1A1HPGDKDM4ERECQLPOLB
SCHEMBL30231669 0.82 ALDH1A1 (0.57) ALDH1A1HPGDKDM4ERECQLPOLB
SCHEMBL30231670 0.82 ALDH1A1 (0.57) ALDH1A1HPGDKDM4ERECQLPOLB
SCHEMBL21629540 0.81 ALDH1A1 (1.00) ALDH1A1HPGDKDM4ERECQLPOLB
SCHEMBL21629541 0.81 ALDH1A1 (1.00) ALDH1A1HPGDKDM4ERECQLPOLB
SCHEMBL5332450 0.78 ALDH1A1 (0.78) ALDH1A1HPGDKDM4ERECQLPOLB
SCHEMBL26105762 0.77 ALDH1A1 (0.75) ALDH1A1HPGDKDM4ERECQLPOLB
SCHEMBL26104548 0.75 ALDH1A1 (0.71) ALDH1A1HPGDKDM4ERECQLPOLB
SCHEMBL21648249 0.75 MAP1LC3B (0.74) ALDH1A1HPGDKDM4EKMT2AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10703735-B2 4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer LEAD DISCOVERY CENTER GMBH (DE) 2020-07-07 — — US disclosed
US-20200031794-A1 4-PHENYL-COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER LEAD DISCOVERY CENTER GMBH (DE) 2020-01-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200031794-A1 4-PHENYL-COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER POLRMT, COX4I1, UQCRC2 ALDH1A1 1344/4885HPGD 1377/4885KDM4E 1057/4885
US-10703735-B2 4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer POLRMT, COX4I1, UQCRC2 ALDH1A1 1344/4885HPGD 1377/4885KDM4E 1057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback